167 related articles for article (PubMed ID: 3698175)
1. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
Jones MM; Basinger MA; Mitchell WM; Bradley CA
Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
[TBL] [Abstract][Full Text] [Related]
2. Control of nephrotoxicity in the rat during repeated cis-platinum treatments.
Jones MM; Basinger MA
J Appl Toxicol; 1989 Aug; 9(4):229-33. PubMed ID: 2778256
[TBL] [Abstract][Full Text] [Related]
3. Control of some aspects of cis-platinum nephrotoxicity.
Jones MM; Basinger MA; Craft WD; Domingo JL; Llobet JM
Arch Toxicol; 1986 Oct; 59(3):167-71. PubMed ID: 3028320
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats.
Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
J Appl Toxicol; 1995; 15(4):267-73. PubMed ID: 7594195
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice.
Shimada H; Takahashi K; Funakoshi T; Kojima S
Biol Pharm Bull; 1993 Apr; 16(4):368-71. PubMed ID: 8358386
[TBL] [Abstract][Full Text] [Related]
6. Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity.
Jones MM; Basinger MA; Holscher MA
Toxicology; 1991; 68(3):227-47. PubMed ID: 1896997
[TBL] [Abstract][Full Text] [Related]
7. Dithiocarbamate-induced biliary platinum excretion and the control of cis-platinum nephrotoxicity.
Basinger MA; Jones MM; Gilbreath SG; Walker EM; Fody EP; Mayhue MA
Toxicol Appl Pharmacol; 1989 Feb; 97(2):279-88. PubMed ID: 2538006
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
Hidaka S; Tsuruoka M; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
Ren Fail; 1994; 16(3):337-49. PubMed ID: 8059017
[TBL] [Abstract][Full Text] [Related]
9. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
[TBL] [Abstract][Full Text] [Related]
10. The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.
Reznik LV; Myazina EM; Shakchmatova EI; Gambaryan SP; Brovtsyn VK; Natochin YV; Jones MM
Br J Cancer; 1991 Feb; 63(2):234-6. PubMed ID: 1847647
[TBL] [Abstract][Full Text] [Related]
11. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
[TBL] [Abstract][Full Text] [Related]
12. Prevention of renal toxicity of cis-diamminedichloroplatinum by dithiocarbamates in rats.
Shimada H; Sugimachi N; Funakoshi T; Kojima S
Toxicol Lett; 1993 Feb; 66(2):193-8. PubMed ID: 8430439
[TBL] [Abstract][Full Text] [Related]
13. Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
Carfagna PF; Chaney SG; Chang J; Holbrook DJ
Fundam Appl Toxicol; 1990 May; 14(4):706-19. PubMed ID: 2163338
[TBL] [Abstract][Full Text] [Related]
14. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
Osman NM; Copley MP; Litterst CL
Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
DeWoskin RS; Riviere JE
Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
[TBL] [Abstract][Full Text] [Related]
16. The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.
Graziano J; Jones B; Pisciotto P
Br J Pharmacol; 1981 Jul; 73(3):649-54. PubMed ID: 6265016
[TBL] [Abstract][Full Text] [Related]
17. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
18. Protection against cis-diamminedichloroplatinum-induced nephrotoxicity in rats by N-benzyl-D-glucamine dithiocarbamate.
Kiyozumi M; Inoue T; Kojima S; Hidaka S; Tsuruoka M
Toxicology; 1991 Mar; 67(1):41-51. PubMed ID: 2017764
[TBL] [Abstract][Full Text] [Related]
19. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
Montine TJ; Borch RF
Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
[TBL] [Abstract][Full Text] [Related]
20. L-methionine suppresses pathological sequelae of cis-platinum in the rat.
Basinger MA; Jones MM; Holscher MA
Fundam Appl Toxicol; 1990 Apr; 14(3):568-77. PubMed ID: 2340984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
